BSEInsider Trading / SAST29 Sept 2026 · 29 Sept 2026, 06:18 pm

Intimation of closure of trading window under ther SEBI (Prohibition of Insider trading) Regulation, 2015.

KMS Medisurgi Ltd · 540468

✦ AI Summary

KMS Medisurgi Ltd has announced the closure of its trading window under the SEBI (Prohibition of Insider Trading) Regulations, 2015, effective from October 1, 2026, until 48 hours after the declaration of its half-yearly financial results.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

KMS Medisurgi Ltd - 540468 - Closure of Trading Window

Attachments (1)

📄

924b1b71-329f-4e42-ab9f-2e6f4208cfab.pdf

pdf

Download →
View document text
KMS MEDISURGI LIMITED Plot No-297/301 May Building, Gr. Floor Marine lines (EAST), Princess Street, ® Mumbai 400 002 Maharashtra (India) ) CIN: L51397MH1999PLC119118 Website: www.kmsgroup.in | E-mail Id: cskms99@gmail,com Tel: 022-66107700/22, 022-67498822 | Fax: +91-22-22061111 Date: 29.09.2026 BSE Limited Corporate Relationship Department Ist Floor, New Trading Ring, Rotunda Building, P. J. Towers, Dalal Street, Fort, Mumbai — 400 001 Sub: Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015 Ref: KMS Medisurgi Limited — Scrip Code: 540468 Dear Sir/Madam, This is to inform you that pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company shall remain closed for all Designated Persons and their Immediate Relatives with effect from Thursday, October 1, 2026, and shall remain closed until 48 hours after the declaration of the duly approved Financial Results of the Company for the half year ended September 30, 2026. Accordingly, all Designated Persons and their Inmediate Relatives have been intimated not to trade in the securities of the Company during the aforesaid period of closure of the Trading Window. The date of the Board Meeting for consideration and approval of the Financial Results of the Company for the half year ended September 30, 2026, will be intimated to the Stock Exchange in due course, in accordance with the applicable provisions. You are requested to kindly take the above information on record. Thanking you, Yours faithfully, For KMS MEDISURGI LIMITED FOR KMS mum_ LUMITED N Siddharth Kanakia Managing Director DIN: 07595098 Place: Mumbai